GVR Report cover Lipid Market Size, Share & Trends Report

Lipid Market Size, Share & Trends Analysis Report By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Application, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-930-2
  • Number of Pages: 95
  • Format: Electronic (PDF)

Report Overview

The global lipid market size was valued at USD 6.67 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030. Rising consumption of the product in the development of vaccines for COVID-19 has escalated its market growth globally. According to the Partners in Health in January 2022, the world needs over 22 Million more vaccines to stabilize the effects of COVID-19 by the end of 2023 and bring it under control. This is expected to increase the global demand for lipids over the forecast period.

 U.S. Lipid Market size, by product, 2020 - 2030 (USD Million)

Lipids are considered as an essential ingredient in the formulation of dietary supplements owing to its high content of energy and fat-soluble vitamins. Increasing health concern among people in light of the COVID-19 has propelled the demand for dietary supplements across the globe. Furthermore, availability of dietary supplements in multiple forms and in a variety of flavors has made it more socially acceptable by all age groups of people. Growing dietary supplement consumption is expected to boost the demand for lipids over the projected years.

Lipids are highly influential component for the development of mRNA-based vaccines for COVID-19. Massive demand for it in the development of COVID-19 vaccines for global population has compelled the manufacturers to ramp up their lipid production. In February 2021, Merck KGaA revealed that they have been working tirelessly to expand their lipid production capacity. In February 2021, Evonik Industries also shared its plan to accelerate its production at two plants in Germany. This has been a contributing factor for the growth of the market over the past two years.

Rapid increase in population in regions like Asia Pacific, Europe, and North America is expected to contribute to the demand products such as pharmaceutical & healthcare, dietary supplements, functional food, functional beverages, cosmetic & personal care, and more. High content of omega 3 and omega 6 in lipids is the primary factor driving the significant use of it in food & beverage products.

The rising global prices of fatty acids and other raw materials act as a barrier to the growth of the market worldwide. These price fluctuations are a repercussion of the impact of the COVID-19 and the ongoing European geopolitical conflict. In North America, the price of fatty acids fluctuated in the first quarter of 2022 on the account of decline in demand for fatty acids from personal care, cosmetic, and food industry. Furthermore, American fatty acids manufacturers had to face supply shortages from Asian countries.

Product Insights

Triglycerides dominated the market with the highest revenue share of 43.9 % in 2021. Its high share is attributable to the increasing demand for their derivatives, namely medium chain triglycerides, and long chain triglycerides, from end-use industries such as functional beverages and dietary supplements among others. Triglycerides lipids are the prominent source of energy, as a result, it is extensively used in a wide variety of functional food and functional beverages.

Phospholipids segment is expected to register a substantial growth over the forecast period owing to its superior properties of imparting of omega-3 fats throughout the entire body, making it a prominent ingredient in the production of functional food and dietary supplements. Furthermore, rising use of phospholipids in a range of pharmaceutical technology as emulsifiers, wetting agents, and builder of micelles, cubosomes, liposomes, and others is anticipated to drive demand for phospholipids over the foreseeable future globally.

The increasing demand for sphingolipids from a variety of end-use industries, including cosmetic and personal care and other applications, are responsible for the expansion of this market. The growth of this segment is also being further fueled by the rising level of awareness about the advantages of sphingolipids.

Lipid nanoparticles and the ongoing clinical trials for mRNA-based vaccines against COVID-19 were made possible by significant production of ionizable lipids with higher in vivo potency. The market may expand as a result of research efforts to create ionizable lipids with enhanced properties. The growth of the market can be attributed to the continuous research and investment made in the research and development of drug delivery systems.

Phase Insights

Clinical phase segment was the second largest market with the revenue share of 18.3% in 2021. Its high share is attributable to growing demand for lipid as specialty chemicals for the production of printing inks, lubricants, surfactants, pesticide adjuvants, fuels, etc. used in different industrial applications. It is increasingly being adopted as a feasible and environment-friendly alternative in the fuels and plastics industry.

The clinical utilization of lipids involves the usage of selective dietary supplements containing the chemical for treating various chronic inflammatory diseases across the world. The increasing use of different mRNA patterns in clinical approaches for treating various health conditions in humans by key functional companies is projected to positively impact the growth of clinical phase segment market across the world during the forecast period.

Strict regulatory scenarios regarding the development of lipids typically lead to a reduced number of drug approvals from regulatory bodies and vaccine development programs. This impacts its utilization in pre-clinical applications worldwide. Increased government intervention in the pre-clinical studies is, however, anticipated to slow down the growth of pre-clinical phase segment market in the coming years.

Application Insights

Food & beverages dominated the market with the highest revenue share of 35% in 2021. Its high share is attributable to growing food & beverages industry across the globe owing to rapid increase in population. Lipids are mainly utilized for preparing functional food and functional beverages due to its advantageous properties of high source of energy and vitamins. Growing health risk amid the outrageous situation of COVID-19 has propelled the demand for food and beverages that contain nutritional components. Excessive demand for nutritional food and healthy beverages is anticipated to boost the demand for the product in food & beverages industry over the projected years.

 Global Lipid Market revenue share, by application, 2021 (%)

The demand for lipids in pharmaceutical applications is expected to rise due to its increasing use in drug development and many other pharmaceutical applications. Especially, it is among the key ingredients that helped in the development of COVID-19 vaccines in 2021.   It is regarded as fundamental excipients in the pharmaceutical industry for the production of the majority of dosage forms. Increasing significance of medicines and drug amid the growing health concerns is likely to elevate the demand for pharmaceuticals, thereby, will create lucrative growth opportunities for lipids in the near future.

Rising intake of nutrition and supplements coupled with increased public awareness regarding health and fitness. The segment is driven by customers that need to maintain and satisfy their daily nutritional requirements. Lipids in the diet affect the food's texture, flavor, and caloric content. It plays a variety of roles in the human body such as the absorption of fat-soluble nutrients and vitamins as a source of stored energy.

Regional Insights

Asia Pacific dominated the lipid market with the highest revenue share of 39% in 2021. This is attributed to the increasing demand dietary supplements, functional food, functional beverages, pharmaceuticals, and more. The outbreak of the pandemic has made unprecedented changes in people’s lifestyles and priorities. People in the Asia Pacific region are now more concerned about their health than they have ever been before. As a result, the consumption of dietary supplements, functional food products, and medicines, among others, has significantly increased in the last few years and is likely to continue to grow in the coming years owing to rising health concerns in Asia Pacific.

North America was severely impacted by COVID-19, with the maximum fatality recorded in the U.S. across all the countries in the world. This factor has increased awareness among North Americans to follow strict precautionary measures and consume foods that boost the immune system. Thus, dietary supplements and functional foods have become an essential part of people’s daily diet in North America. Increasing consumption of dietary supplements and functional foods is expected to drive the demand for lipids in North America over the forthcoming years.

Lipid Market Trends by Region

Europe is one of the prominent regions with a robust pharmaceutical & medical sector. The research-based pharmaceutical industry in Europe plays a critical role in the region’s growth. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2020, Europe emerged as the second-largest pharmaceutical products seller with 23.9% of the total pharmaceutical sales. The extensive usage of lipids in the production of vaccines and the in-house large-scale production carried out by various companies in Europe are expected to have a positive impact on the overall market growth.

Key Companies & Market Share Insights

Lipid market is heavily fragmented with presence of a huge number of major innovative players such as Merck KGaA, Evonik Industries AG, Kerry Group plc, Archer Daniels Midland Company (ADM), and others. The competition is growing as the manufacturers are engaged in increasing customer base to have a competitive edge over each other.Some prominent players in the global lipid market comprise of:

  • Precision NanoSystems

  • Evonik Industries AG

  • Merck KGaA

  • Genevant Sciences

  • Exelead

  • Avanti Polar Lipids

  • Nippon Fine Chemicals Co. Ltd.

  • Lipoid GmbH

  • Cargill, Incorporated


  • Archer Daniels Midland Company

  • Koninklijke DSM N.V.

  • Kerry Group plc

  • Nordic Naturals, Inc.

  • Clover Corporation

  • Croda International plc

  • Lipoid Kosmetik AG

  • Omega Protein Corporation

Lipid Market Report Scope

Report Attribute


Market size value in 2022

USD 6.59 billion

Revenue forecast in 2030

USD 12.85 billion

Growth rate

CAGR of 8.7 % from 2022 to 2030

Base year for estimation


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Volume in Kilotons, Revenue in USD Million, and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, Phase, Application, and Region

Regional scope

North America, Europe, Asia Pacific, Central & South America, Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, UK, France, Spain, Italy, Belgium, Russia, Turkey, China, India, Japan, Australia, Indonesia, Thailand, Philippines, Malaysia, Vietnam, South Korea, Brazil, Argentina, Colombia, Saudi Arabia, South Africa, UAE, Egypt, Nigeria.

Key companies profiled

Precision NanoSystems, Evonik Industries AG, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemicals Co. Ltd., Lipoid GmbH, Cargill, Incorporated, BASF SE, Archer Daniels Midland Company, Koninklijke DSM N.V., Kerry Group plc, Nordic Naturals, Inc., Clover Corporation, Croda International plc, Lipoid Kosmetik AG, Omega Protein Corporation

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Lipid Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the Lipid market report on the basis of product, phase, application, and region:

Global Lipid Market Segmentation

  • Product Outlook (Volume, Kilotons, Revenue, USD Million; 2018 - 2030)

    • Ionizable Lipids (Lipid Nano Particles)

      • mRNA

      • siRNA

      • Others

    • Triglycerides

    • Sphingolipids

    • Phospholipids

    • Others

  • Phase Outlook (Volume, Kilotons, Revenue, USD Million; 2018 - 2030)

    • Clinical

    • Pre-clinical

    • Others

  • Application Outlook (Volume, Kilotons, Revenue, USD Million; 2018 - 2030)

    • Pharmaceuticals

      • Vaccines and Drugs

      • Scientific Research

    • Nutrition & Supplements

    • Food & Beverages

    • Others

  • Regional Outlook (Volume, Kilotons, Revenue, USD Million; 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • Germany

      • UK

      • France

      • Spain

      • Italy

      • Belgium

      • Russia

      • Turkey

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • Indonesia

      • Thailand

      • Philippines

      • Malaysia

      • Vietnam

      • South Korea

    • Central & South America

      • Brazil

      • Argentina

      • Colombia

    • Middle East & Africa

      • Saudi Arabia

      • South Africa

      • UAE

      • Egypt

      • Nigeria

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon